ciprofloxacin has been researched along with cephradine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bevan, JS; Gibby, OM; Griffiths, GJ; Williams, JD | 1 |
| Dunstan, FD; Fitzgerald, KA; Howard, AJ; Magee, JT | 1 |
| Barry, L; Corcoran, GD; Hooton, C; Lucey, B; O'Grady, MC; O'Halloran, C; Walsh, N | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
1 review(s) available for ciprofloxacin and cephradine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for ciprofloxacin and cephradine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Bilateral renal cortical abscesses in a young woman with type 1 diabetes.
Topics: Abscess; Adult; Cephradine; Ciprofloxacin; Cloxacillin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney Cortex; Kidney Diseases | 1989 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cephalexin; Cephradine; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim; Urinary Tract Infections | 2001 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Cephradine; Ciprofloxacin; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2018 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |